4.6 Article

SUMO2/3 conjugation is an endogenous neuroprotective mechanism

Journal

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
Volume 31, Issue 11, Pages 2152-2159

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/jcbfm.2011.112

Keywords

endogenous neuroprotection; lentiviral microRNA delivery; oxygen-glucose deprivation; SUMO conjugation

Funding

  1. European Union [201024]
  2. European Union (European Stroke Network) [202213]
  3. German Research Foundation [TR43, DFG-EXC 257, KFO213 (HA5741)]
  4. VolkswagenStiftung
  5. Bundesministerium fur Bildung und Forschung (Center for Stroke Research Berlin)
  6. National Institutes of Health [HL095552]

Ask authors/readers for more resources

Small ubiquitin-like modifier (SUMO) 2/3 but not SUMO1 conjugation is activated after transient cerebral ischemia. To investigate its function, we blocked neuronal SUMO2/3 translation through lentiviral microRNA delivery in primary cortical neurons. Viability was unaffected by SUMO2/3 silencing unless neurons were stressed by transient oxygen-glucose deprivation (OGD). Both 15 and 45 minutes of OGD were tolerated by control microRNA-expressing neurons but damaged >60% of neurons expressing SUMO2/3 microRNA. Damaging OGD (75 minutes) increased neuronal loss to 54% (control microRNA) and to 99% (SUMO2/3 microRNA). This suggests that activation of SUMO2/3 conjugation is an endogenous neuroprotective stress response. Journal of Cerebral Blood Flow & Metabolism (2011) 31, 2152-2159; doi:10.1038/jcbfm.2011.112; published online 24 August 2011

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available